In October 2007, the FDA introduced the labeling for all PDE5 inhibitors, which include tadalafil, requires a much more popular warning on the opportunity risk of sudden hearing reduction as the results of article-marketing stories of short term deafness related to use of PDE5 inhibitors.[19]are allergic to sildenafil, as contained in VIAGRA and Re